UniProt ID | PERM_HUMAN | |
---|---|---|
UniProt AC | P05164 | |
Protein Name | Myeloperoxidase | |
Gene Name | MPO | |
Organism | Homo sapiens (Human). | |
Sequence Length | 745 | |
Subcellular Localization | Lysosome. | |
Protein Description | Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity.. | |
Protein Sequence | MGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAAPAVLGEVDTSLVLSSMEEAKQLVDKAYKERRESIKQRLRSGSASPMELLSYFKQPVAATRTAVRAADYLHVALDLLERKLRSLWRRPFNVTDVLTPAQLNVLSKSSGCAYQDVGVTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAARASFVTGVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MGVPFFSSLRCMVDL CCCCCHHCCEEEEEC | 18.06 | 24719451 | |
90 | Phosphorylation | SIKQRLRSGSASPME HHHHHHHCCCCCHHH | 41.51 | 23532336 | |
92 | Phosphorylation | KQRLRSGSASPMELL HHHHHCCCCCHHHHH | 27.16 | 28450419 | |
94 | Phosphorylation | RLRSGSASPMELLSY HHHCCCCCHHHHHHH | 26.86 | 28857561 | |
103 | Acetylation | MELLSYFKQPVAATR HHHHHHHHCCHHCCH | 45.52 | 61193 | |
132 | Phosphorylation | LLERKLRSLWRRPFN HHHHHHHHHHCCCCC | 42.60 | 24719451 | |
139 | N-linked_Glycosylation | SLWRRPFNVTDVLTP HHHCCCCCHHHCCCH | 38.16 | 16335952 | |
172 | Acetylation | VTCPEQDKYRTITGM CCCCCCCCCHHHHHH | 36.00 | 26822725 | |
187 | Phosphorylation | CNNRRSPTLGASNRA CCCCCCCCCCCCCCH | 38.79 | 23312004 | |
191 | Phosphorylation | RSPTLGASNRAFVRW CCCCCCCCCCHHEEE | 25.67 | 23312004 | |
231 | Phosphorylation | VALARAVSNEIVRFP HHHHHHHHCCCCCCC | 27.97 | 24247654 | |
316 | Sulfation | CIPFFRSCPACPGSN CCHHHHCCCCCCCCC | 1.84 | 7840679 | |
316 | Oxidation | CIPFFRSCPACPGSN CCHHHHCCCCCCCCC | 1.84 | 7840679 | |
316 | Cysteine sulfenic acid (-SOH) | CIPFFRSCPACPGSN CCHHHHCCCCCCCCC | 1.84 | - | |
322 | O-linked_Glycosylation | SCPACPGSNITIRNQ CCCCCCCCCCCHHHH | 15.36 | 28657654 | |
323 | N-linked_Glycosylation | CPACPGSNITIRNQI CCCCCCCCCCHHHHH | 41.14 | 16740002 | |
323 | N-linked_Glycosylation | CPACPGSNITIRNQI CCCCCCCCCCHHHHH | 41.14 | 20332087 | |
355 | N-linked_Glycosylation | PLARNLRNMSNQLGL HHHHHHHHHHHHHCH | 41.21 | 1334087 | |
355 | N-linked_Glycosylation | PLARNLRNMSNQLGL HHHHHHHHHHHHHCH | 41.21 | 1334087 | |
357 | Phosphorylation | ARNLRNMSNQLGLLA HHHHHHHHHHHCHHH | 25.60 | 25278378 | |
391 | N-linked_Glycosylation | DDPCLLTNRSARIPC CCCCCCCCCCCCCCE | 35.56 | 1334087 | |
391 | N-linked_Glycosylation | DDPCLLTNRSARIPC CCCCCCCCCCCCCCE | 35.56 | 1334087 | |
428 | Phosphorylation | REHNRLATELKSLNP HHHHHHHHHHHHHCC | 46.58 | 20736484 | |
432 | Phosphorylation | RLATELKSLNPRWDG HHHHHHHHHCCCCCH | 46.10 | - | |
470 | Phosphorylation | LPLVLGPTAMRKYLP HHHHHCHHHHHHHCC | 31.15 | 27499020 | |
481 | Phosphorylation | KYLPTYRSYNDSVDP HHCCCCCCCCCCCCH | 20.20 | 23403867 | |
482 | Phosphorylation | YLPTYRSYNDSVDPR HCCCCCCCCCCCCHH | 17.62 | 23403867 | |
483 | N-linked_Glycosylation | LPTYRSYNDSVDPRI CCCCCCCCCCCCHHH | 36.01 | 16740002 | |
500 | Phosphorylation | VFTNAFRYGHTLIQP HHHHHHHHCCCCHHC | 13.55 | 18083107 | |
516 | Phosphorylation | MFRLDNRYQPMEPNP HEECCCCCCCCCCCC | 24.19 | 29083192 | |
516 | Nitrated tyrosine | MFRLDNRYQPMEPNP HEECCCCCCCCCCCC | 24.19 | - | |
528 | Phosphorylation | PNPRVPLSRVFFASW CCCCCCHHHHHHHEH | 21.96 | - | |
625 | Sumoylation | GTVLRNLKLARKLME HHHHHHHHHHHHHHH | 43.58 | - | |
625 | Sumoylation | GTVLRNLKLARKLME HHHHHHHHHHHHHHH | 43.58 | - | |
687 | Phosphorylation | WENEGVFSMQQRQAL CCCCCCCCHHHHHHH | 17.18 | 29802988 | |
698 | Phosphorylation | RQALAQISLPRIICD HHHHHHCCCCEEECC | 21.90 | 24719451 | |
707 | Phosphorylation | PRIICDNTGITTVSK CEEECCCCCCEEEEC | 19.40 | 29978859 | |
710 | Phosphorylation | ICDNTGITTVSKNNI ECCCCCCEEEECCCE | 23.61 | 29978859 | |
711 | Phosphorylation | CDNTGITTVSKNNIF CCCCCCEEEECCCEE | 22.36 | 29978859 | |
713 | Phosphorylation | NTGITTVSKNNIFMS CCCCEEEECCCEECC | 27.81 | 29978859 | |
720 | Phosphorylation | SKNNIFMSNSYPRDF ECCCEECCCCCCCCC | 16.33 | 21552520 | |
723 | Phosphorylation | NIFMSNSYPRDFVNC CEECCCCCCCCCCCC | 13.41 | 21552520 | |
729 | N-linked_Glycosylation | SYPRDFVNCSTLPAL CCCCCCCCCCCCCCC | 17.64 | 20332087 | |
729 | N-linked_Glycosylation | SYPRDFVNCSTLPAL CCCCCCCCCCCCCCC | 17.64 | 17623646 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PERM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PERM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PERM_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PERM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
254600 | Myeloperoxidase deficiency (MPOD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-355 AND ASN-391, AND MASSSPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-323 AND ASN-483, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-139 AND ASN-483, AND MASSSPECTROMETRY. | |
"Glycosylation pattern of mature dimeric leukocyte and recombinantmonomeric myeloperoxidase: glycosylation is required for optimalenzymatic activity."; Van Antwerpen P., Slomianny M.C., Boudjeltia K.Z., Delporte C.,Faid V., Calay D., Rousseau A., Moguilevsky N., Raes M., Vanhamme L.,Furtmueller P.G., Obinger C., Vanhaeverbeek M., Neve J.,Michalski J.C.; J. Biol. Chem. 285:16351-16359(2010). Cited for: PROTEIN SEQUENCE OF 49-53, SUBUNIT, GLYCOSYLATION AT ASN-323; ASN-355;ASN-391; ASN-483 AND ASN-729, AND MASS SPECTROMETRY. |